Fennec Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Fennec Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Fennec Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Fennec Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $98k | 16k | 6.32 |
2024-09-30 | $56k | 11k | 5.00 |
2024-06-30 | $44k | 7.3k | 6.11 |
2024-03-31 | $329k | 30k | 11.12 |
2023-12-31 | $224k | 20k | 11.22 |
2023-09-30 | $75k | 10k | 7.51 |
2023-06-30 | $93k | 11k | 8.83 |
2023-03-31 | $5.9k | 705 | 8.31 |
2022-12-31 | $614 | 64 | 9.59 |
2022-09-30 | $48k | 3.1k | 15.63 |
2022-06-30 | $0 | 64 | 0.00 |
2022-03-31 | $0 | 1.1k | 0.00 |
2021-12-31 | $0 | 7.8k | 0.00 |
2021-09-30 | $1.0k | 64 | 15.63 |
2021-06-30 | $430k | 59k | 7.29 |
2021-03-31 | $252k | 41k | 6.21 |
2020-12-31 | $26k | 3.6k | 7.32 |
2020-06-30 | $58k | 6.9k | 8.42 |
2019-12-31 | $6.0k | 983 | 6.10 |
2019-09-30 | $11k | 2.3k | 4.78 |
2019-06-30 | $0 | 107 | 0.00 |
2019-03-31 | $2.0k | 311 | 6.43 |
2018-12-31 | $46k | 7.2k | 6.39 |
2018-09-30 | $23k | 2.8k | 8.22 |
2018-06-30 | $45k | 4.3k | 10.48 |
2017-12-31 | $8.0k | 813 | 9.84 |
2017-09-30 | $1.0k | 79 | 12.66 |